Damé Idossa
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
- Oncology 11
- HER2/EGFR in Cancer Research 5
- Cancer Treatment and Pharmacology 4
- Global Cancer Incidence and Screening 3
-
- Advanced Breast Cancer Therapies 3
- Co-authors
- Laura A. Huppert (5 shared papers)Hope S. Rugo (5 shared papers)Özge Gümüşay (1 shared paper)Douglas A. Simonetto (1 shared paper)Rhett P. Ketterling (2 shared papers)Ayalew Tefferi (2 shared papers)Christy M. Finke (2 shared papers)Mrinal M. Patnaik (2 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)JCO Oncology Practice (3 papers)American Journal of Hematology (2 papers)Cancer Research (2 papers)CA A Cancer Journal for Clinicians (1 paper)
- Partner nations
- United StatesIndiaTürkiye
In The Last Decade
Damé Idossa
19 papers receiving 253 citations
Damé Idossa's Hit Papers
Peers
Comparison fields: 5 of 62
- Hematology 73
- Genetics 59
- Oncology 107
- Cancer Research 53
- Pulmonary and Respiratory Medicine 77
Countries citing papers authored by Damé Idossa
This map shows the geographic impact of Damé Idossa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damé Idossa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damé Idossa more than expected).
Fields of papers citing papers by Damé Idossa
This network shows the impact of papers produced by Damé Idossa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damé Idossa. The network helps show where Damé Idossa may publish in the future.
Co-authors
The 25 scholars most cited alongside Damé Idossa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer Hit paper breakdown → | 2023 | 96 |
| 2 | 2017 | 56 | |
| 3 | 2018 | 21 | |
| 4 | 2017 | 21 | |
| 5 | 2019 | 18 | |
| 6 | 2024 | 13 | |
| 7 | 2024 | 7 | |
| 8 | 2025 | 4 | |
| 9 | 2022 | 3 | |
| 10 | 2022 | 3 | |
| 11 | 2017 | 3 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 2 | |
| 14 | 2023 | 2 | |
| 15 | 2024 | 1 | |
| 16 | 2023 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2022 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2025 | 0 |
About Damé Idossa
Damé Idossa is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Gender Studies, Economics and Econometrics and Genetics, having authored 22 papers that have together received 256 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (5 papers), Cancer Treatment and Pharmacology (4 papers), Diversity and Career in Medicine (4 papers), Economic and Financial Impacts of Cancer (3 papers), Advanced Breast Cancer Therapies (3 papers), Global Cancer Incidence and Screening (3 papers), Breast Cancer Treatment Studies (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (73 citations), Genetics (59 citations), Oncology (107 citations), Cancer Research (53 citations) and Pulmonary and Respiratory Medicine (77 citations). Damé Idossa has collaborated with scholars based in United States, India and Türkiye. Frequent co-authors include Laura A. Huppert, Hope S. Rugo, Özge Gümüşay, Douglas A. Simonetto, Rhett P. Ketterling, Ayalew Tefferi, Christy M. Finke, Mrinal M. Patnaik, Animesh Pardanani and Terra L. Lasho. Their work appears in journals such as Journal of Clinical Oncology, JCO Oncology Practice, American Journal of Hematology, Cancer Research and CA A Cancer Journal for Clinicians.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.